Who Paid My Doc
Robert Holleman
Pediatric Nephrology Columbia, SC Medical Doctor
NPI 1639109903 CMS profile 1206934
9 Richland Medical Park Dr Ste 270, Columbia, SC 29203
General payments
$24
Research payments
$0
Ownership & investment interest
$0
Through program year 2021, Robert Holleman of Columbia, SC is reported in the CMS Open Payments database as having received $24 across 2 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 8th percentile of Pediatric Nephrology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2021 | General | $24 | 2 |
Beside peers
- Robert Holleman
- Pediatric Nephrology median
- Middle half of Pediatric Nephrology
- National median
In program year 2025, general payments to Robert Holleman were reported at $0. Among 327 Pediatric Nephrology profiles paid that year, the median was $131 and the middle half received between $47 and $474.
Show as a table
| Year | Robert Holleman | Pediatric Nephrology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $123 | $48–$353 | $163 |
| 2020 | $0 | $146 | $24–$2,251 | $114 |
| 2021 | $24 | $138 | $26–$1,371 | $132 |
| 2022 | $0 | $93 | $25–$427 | $149 |
| 2023 | $0 | $105 | $30–$375 | $160 |
| 2024 | $0 | $123 | $40–$481 | $164 |
| 2025 | $0 | $131 | $47–$474 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 1 drugPart D claims
12
Drug cost
$97
Branded share of claims
0%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Amlodipine Besylate | Generic | 12 | $97 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 9,003 Part D prescribers listed as Nephrology; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 16 billing codesPaid by Medicare
$19,254
Medicare patients
11
Services billed
195
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| Diabetes | 0% | |
| Ischemic heart disease | 0% | |
| Atrial fibrillation | 0% | |
| COPD | 0% | |
| Cancer | 0% | |
| Osteoporosis | 0% | |
| Alzheimer's or dementia | 0% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
2 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Pediatric Nephrology in South Carolina
David Selewski
Pediatric Nephrology · Charleston, SC
Lindsey Gordon
Pediatric Nephrology · Columbia, SC
Oana Nicoara
Pediatric Nephrology · Charleston, SC
Anita Perez
Pediatric Nephrology · Charleston, SC
Sudha Garimella
Pediatric Nephrology · Greenville, SC
Monica Cramer
Pediatric Nephrology · Columbia, SC
Related records
Pediatric Nephrology in South Carolina
Practitioners in the same specialty and state, ranked by reported value.
All Pediatric Nephrology
Everyone recorded under this specialty, nationwide.
Doctors in South Carolina
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.